Applied Materials Completes Acquisition of Precision Wafering Supplier

Applied Materials, Inc. today announced that it has completed the acquisition of HCT Shaping Systems SA (HCT), the world’s leading supplier of precision wafering systems for manufacturing crystalline silicon (c-Si) substrates for the solar industry. The acquisition expands Applied’s portfolio of solutions for helping solar customers reduce the costs of manufacturing photovoltaic (PV) cells to make solar energy more competitive with grid electricity.

Under the terms of the agreement, originally announced on June 26, 2007, Applied paid approximately CHF 583 million (or approximately US$483 million) in cash for all of the outstanding shares of HCT, a privately-held company based in Switzerland.

“This acquisition, combined with our strong production technology and global support infrastructure, will enable us to bring crystalline silicon solar manufacturing to a new level of efficiency and help drive down the cost-per-watt of solar power,” said Mike Splinter, president and CEO of Applied Materials. “HCT’s technology is critical to our roadmap since it complements our high-throughput deposition systems and will enable customers to scale up production and reduce costs.”

HCT is now part of Applied’s new Precision Wafering Systems division, operating under the Solar Business Group headed by Charles Gay. Stefan Schneeberger, who has been appointed vice president and general manager of the Precision Wafering Systems division, commented, “We are excited to be part of Applied Materials. Our roadmaps are aligned with the goal of bringing new and advanced manufacturing technologies to reduce the cost of solar energy. Together, we will help customers to continuously reduce the grams of silicon needed per watt, while significantly improving their productivity.”

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.